Notable Runner: What Next for Avinger Inc Stock After Touching 52 Week Low?

Notable Runner: What Next for Avinger Inc Stock After Touching 52 Week Low?

The stock of Avinger Inc (NASDAQ:AVGR) hit a new 52-week low and has $3.13 target or 12.00% below today’s $3.56 share price. The 8 months bearish chart indicates high risk for the $74.21M company. The 1-year low was reported on Oct, 28 by If the $3.13 price target is reached, the company will be worth $8.91M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 157,033 shares traded hands. Avinger Inc (NASDAQ:AVGR) has declined 57.80% since March 28, 2016 and is downtrending. It has underperformed by 62.51% the S&P500.

Analysts await Avinger Inc (NASDAQ:AVGR) to report earnings on November, 3. They expect $-1.04 EPS, up 3.70% or $0.04 from last year’s $-1.08 per share. After $-1.06 actual EPS reported by Avinger Inc for the previous quarter, Wall Street now forecasts -1.89% EPS growth.

According to Zacks Investment Research, “Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company’s product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City, California.”

More notable recent Avinger Inc (NASDAQ:AVGR) news were published by: which released: “Avinger Inc. NASDAQ: AVGR” on December 15, 2011, also with their article: “SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation …” published on August 10, 2016, published: “Avinger to Present at Upcoming Investor Conferences” on October 27, 2016. More interesting news about Avinger Inc (NASDAQ:AVGR) were released by: and their article: “Avinger Inc. (AVGR) Lowers Guidance, Stock Down 40%” published on July 13, 2016 as well as‘s news article titled: “Avinger, Inc. Announces Closing of Public Offering of Common Stock and …” with publication date: August 16, 2016.

AVGR Company Profile

Avinger, Inc., incorporated on March 8, 2007, is a commercial-stage medical device company. The Firm designs, makes and sells image-guided, catheter systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Firm focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Firm makes and sells a suite of products in the United States and select European markets. The Company’s products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment